Objective: To review the clinicopathologic characteristics of vulvovag
inal soft-tissue sarcomas, and to correlate these variables with respo
nse to treatment. Methods: We performed a retrospective review of the
records of 24 women treated at Memorial Hospital for sarcoma of either
the vulva or vagina over 20 years (1974-1993). Archival pathology spe
cimens were reviewed to confirm the diagnosis, histology, and grade of
the tumor. Results: Fifteen patients had sarcomas arising from the va
gina and nine had primary vulvar tumors. Leiomyosarcoma was the most c
ommon histology (n = 13). Twenty-three of 24 women underwent surgical
excision as their primary therapy. Twenty-three were available for fol
low-up, and 16 of them (70%) are free of disease at a median follow-up
time of 47 months (range 12-156, mean 59). Five women died of progres
sive disease and two are currently alive with persistent or recurrent
disease. Grade was the most important predictor of outcome; all seven
women with low-grade tumors are alive without evidence of disease. Con
clusion: Soft-tissue sarcomas are rare tumors of the lower genital tra
ct. The primary therapy is surgical; adjuvant radiation therapy is ind
icated for high-grade tumors and locally recurrent low-grade sarcomas.